Skip to main content

Microbial Production of PharmaceuticalsSomatostatin, Humulin and Interferons




Microbial Production of Pharmaceuticals
Somatostatin, Humulin and Interferons


1. Introduction

Advances in recombinant DNA technology have enabled microorganisms to produce human therapeutic proteins safely, economically and in large quantities. Microbial systems such as Escherichia coli and yeast (Saccharomyces cerevisiae) are widely used for the production of pharmaceuticals that were earlier isolated from human or animal tissues.
Important microbial-derived pharmaceuticals include somatostatin, human insulin (Humulin) and interferons.

2. Advantages of Microbial Production of Pharmaceuticals


High yield and rapid production
Cost-effective and scalable
Free from animal pathogens
Consistent product quality
Easy genetic manipulation

3. General Steps in Microbial Production of Recombinant Pharmaceuticals


Isolation of target gene
Construction of recombinant DNA
Insertion into suitable vector
Transformation into host microorganism
Expression of protein
Downstream processing and purification

4. Microbial Production of Somatostatin

About Somatostatin

A 14-amino acid peptide hormone
Inhibits secretion of growth hormone (GH), insulin and glucagon
Used in treatment of acromegaly, endocrine tumors, GI disorders
Production Strategy
Somatostatin is too small and unstable when produced alone in microbes. Hence it is produced as a fusion protein.
Steps Involved
Synthetic DNA coding for somatostatin is prepared
Gene is fused to β-galactosidase gene (lacZ)
Recombinant plasmid is introduced into E. coli
Fusion protein is expressed in large quantity
Fusion protein is purified
Somatostatin is cleaved using cyanogen bromide (CNBr)
Active somatostatin is purified
Significance
First human hormone produced by recombinant DNA technology
Opened the era of recombinant pharmaceuticals
5. Microbial Production of Humulin (Human Insulin)

About Insulin
Hormone regulating blood glucose level
Composed of two polypeptide chains (A and B) linked by disulfide bonds
Used in treatment of diabetes mellitus


Limitations of Animal Insulin


Allergic reactions
Limited supply
Slight structural differences

Recombinant Production Strategy
Insulin is produced either as separate A and B chains or as proinsulin.
Production in E. coli
Synthetic genes for A-chain and B-chain are prepared
Each gene is fused to β-galactosidase gene
Recombinant plasmids introduced into E. coli
A and B chains produced separately
Chains are purified and cleaved from fusion protein
A and B chains are chemically joined to form insulin
Production in Yeast (Saccharomyces cerevisiae)
Proinsulin gene is inserted into yeast plasmid
Yeast expresses proinsulin
Enzymatic processing converts proinsulin to insulin
Commercial Product
Humulin (first recombinant insulin approved in 1982)
6. Microbial Production of Interferons
About Interferons

Group of cytokines with antiviral, anticancer and immunomodulatory properties
Produced naturally by human cells in response to viral infection
Types of Interferons
IFN-α (alpha) – leukocytes
IFN-β (beta) – fibroblasts
IFN-γ (gamma) – T-lymphocytes
Medical Uses
Treatment of viral infections (hepatitis B & C)
Cancer therapy
Multiple sclerosis
Production in Microbes
IFN-α and IFN-β are commonly produced in E. coli
IFN-γ is produced in E. coli or yeast
Production Steps
Isolation of interferon gene (usually IFN-α)
Cloning into expression vector
Transformation into E. coli
Expression of interferon protein
Recovery from inclusion bodies (if formed)
Refolding and purification
Challenges
Formation of inclusion bodies
Lack of post-translational modifications in bacteria
Protein folding issues

7. Downstream Processing

Cell lysis
Protein purification (chromatography)
Refolding of protein
Quality control and formulation

8. Advantages of Recombinant Interferons

High purity
Reduced side effects
Consistent biological activity

10. Applications of Microbial Pharmaceuticals
Treatment of hormonal disorders
Management of diabetes
Antiviral and anticancer therapy
Immunomodulation

11. Conclusion


Microbial production of pharmaceuticals has revolutionized modern medicine by enabling safe, economical and large-scale synthesis of human therapeutic proteins. The successful production of somatostatin, humulin and interferons demonstrates the immense potential of recombinant microorganisms in the pharmaceutical industry and marks a major milestone in biotechnology.


50 MCQs – Microbial Production of Pharmaceuticals


1. Recombinant pharmaceutical proteins are produced mainly using
A. Plants only
B. Animals only
C. Microorganisms
D. Chemicals
✔ Answer: C
2. The most commonly used bacterial host for recombinant protein production is
A. Bacillus subtilis
B. Escherichia coli
C. Pseudomonas aeruginosa
D. Streptomyces
✔ Answer: B
3. Somatostatin is a
A. Enzyme
B. Antibiotic
C. Peptide hormone
D. Vitamin
✔ Answer: C
4. Somatostatin mainly inhibits the secretion of
A. Thyroxine
B. Growth hormone
C. Adrenaline
D. Prolactin
✔ Answer: B
5. Length of somatostatin is
A. 7 amino acids
B. 14 amino acids
C. 21 amino acids
D. 51 amino acids
✔ Answer: B
6. Somatostatin was the first hormone produced by
A. Chemical synthesis
B. Plant tissue culture
C. Recombinant DNA technology
D. Animal extraction
✔ Answer: C
7. Somatostatin gene is usually expressed as a
A. Free peptide
B. Fusion protein
C. Multimer
D. Zymogen
✔ Answer: B
8. β-galactosidase gene used in somatostatin production is
A. trpA
B. lacZ
C. araC
D. tetR
✔ Answer: B
9. Enzyme/chemical used to cleave somatostatin from fusion protein is
A. Trypsin
B. Pepsin
C. Cyanogen bromide
D. Lysozyme
✔ Answer: C
10. Human insulin consists of
A. One polypeptide chain
B. Two polypeptide chains
C. Three polypeptide chains
D. Four polypeptide chains
✔ Answer: B
11. The two chains of insulin are
A. α and β
B. Heavy and light
C. A and B
D. X and Y
✔ Answer: C
12. Total number of amino acids in insulin is
A. 14
B. 21
C. 51
D. 165
✔ Answer: C
13. Insulin deficiency leads to
A. Acromegaly
B. Dwarfism
C. Diabetes mellitus
D. Goitre
✔ Answer: C
14. Commercial recombinant human insulin is called
A. Interferon
B. Somatotropin
C. Humulin
D. Prolactin
✔ Answer: C
15. The first recombinant insulin was approved in
A. 1978
B. 1980
C. 1982
D. 1985
✔ Answer: C
16. Animal insulin differs from human insulin by
A. 1–3 amino acids
B. 5 amino acids
C. 10 amino acids
D. 20 amino acids
✔ Answer: A
17. In E. coli, insulin is produced by
A. Whole insulin gene
B. Proinsulin only
C. Separate A and B chains
D. Mature insulin directly
✔ Answer: C
18. Yeast is preferred for insulin production because
A. It grows faster
B. It performs post-translational modifications
C. It produces antibiotics
D. It forms spores
✔ Answer: B
19. Proinsulin is converted into insulin by
A. Acid hydrolysis
B. Chemical oxidation
C. Enzymatic cleavage
D. Heat treatment
✔ Answer: C
20. Interferons belong to the group of
A. Hormones
B. Enzymes
C. Cytokines
D. Vitamins
✔ Answer: C
21. Interferons are mainly involved in
A. Digestion
B. Photosynthesis
C. Antiviral defense
D. Respiration
✔ Answer: C
22. IFN-α is naturally produced by
A. Fibroblasts
B. T-lymphocytes
C. Leukocytes
D. Macrophages only
✔ Answer: C
23. IFN-β is produced by
A. Leukocytes
B. Fibroblasts
C. T-cells
D. B-cells
✔ Answer: B
24. IFN-γ is produced by
A. Fibroblasts
B. Leukocytes
C. T-lymphocytes
D. Platelets
✔ Answer: C
25. Recombinant interferons are mainly produced in
A. Plants
B. Animals
C. Bacteria and yeast
D. Algae
✔ Answer: C
26. One major medical application of interferons is treatment of
A. Diabetes
B. Cancer
C. Goitre
D. Hypertension
✔ Answer: B
27. Interferons inhibit viral replication by
A. Destroying host DNA
B. Blocking protein synthesis
C. Activating antiviral enzymes
D. Killing host cells
✔ Answer: C
28. Major problem during bacterial expression of interferons is
A. Slow growth
B. Inclusion body formation
C. Low plasmid copy number
D. Antibiotic resistance
✔ Answer: B
29. Inclusion bodies are
A. Secretory vesicles
B. Aggregates of misfolded proteins
C. Ribosomes
D. Cell organelles
✔ Answer: B
30. Refolding of proteins is required after
A. Transcription
B. Translation
C. Inclusion body solubilization
D. Cell growth
✔ Answer: C
31. Downstream processing includes
A. Gene cloning
B. Fermentation only
C. Protein purification
D. Transformation
✔ Answer: C
32. Chromatography is mainly used for
A. Gene isolation
B. Protein purification
C. Cell growth
D. Mutation induction
✔ Answer: B
33. Recombinant pharmaceuticals are safer because
A. They are cheaper
B. They lack pathogens
C. They are plant-derived
D. They are chemically synthesized
✔ Answer: B
34. Which protein is smallest in size?
A. Insulin
B. Interferon
C. Somatostatin
D. Proinsulin
✔ Answer: C
35. Which protein requires formation of disulfide bonds?
A. Somatostatin
B. Insulin
C. Interferon
D. All of the above
✔ Answer: B
36. Cyanogen bromide cleaves proteins at
A. Arginine
B. Lysine
C. Methionine
D. Tryptophan
✔ Answer: C
37. lac operon system is used in
A. Yeast expression
B. Plant expression
C. Bacterial expression
D. Animal cell culture
✔ Answer: C
38. Recombinant insulin reduced
A. Cost of antibiotics
B. Allergic reactions
C. Hormone deficiency
D. Viral infections
✔ Answer: B
39. Interferons are NOT used for
A. Viral infections
B. Cancer therapy
C. Diabetes treatment
D. Multiple sclerosis
✔ Answer: C
40. IFN-α is commonly used to treat
A. Diabetes
B. Hepatitis
C. Acromegaly
D. Goitre
✔ Answer: B
41. Host system offering eukaryotic processing is
A. E. coli
B. Yeast
C. Bacteriophage
D. Virus
✔ Answer: B
42. Recombinant protein expression requires
A. Only host cell
B. Vector and host
C. Chemical synthesis
D. Heat treatment
✔ Answer: B
43. Promoter controls
A. Protein folding
B. Transcription initiation
C. Translation termination
D. Protein cleavage
✔ Answer: B
44. Insulin produced in yeast is usually synthesized as
A. Mature insulin
B. Proinsulin
C. Separate A and B chains
D. Fusion protein
✔ Answer: B
45. First recombinant pharmaceutical approved for human use was
A. Interferon
B. Somatostatin
C. Insulin
D. Growth hormone
✔ Answer: C
46. Recombinant DNA technology helps in
A. Uniform drug quality
B. Large-scale production
C. Reduced contamination
D. All of the above
✔ Answer: D
47. Insulin chains are linked by
A. Hydrogen bonds
B. Ionic bonds
C. Disulfide bonds
D. Peptide bonds
✔ Answer: C
48. Interferons show which activity?
A. Antibacterial
B. Antiviral
C. Antifungal
D. Antiprotozoal
✔ Answer: B
49. Which is NOT a recombinant pharmaceutical?
A. Insulin
B. Interferon
C. Somatostatin
D. Penicillin
✔ Answer: D
50. Microbial pharmaceutical production represents
A. Traditional biotechnology
B. Medical biotechnology
C. Agricultural biotechnology
D. Environmental biotechnology
✔ Answer: B

Comments

Post a Comment

Popular Posts

AFLP--Amplified Fragment Length Polymorphism

AFLP is a PCR-based DNA fingerprinting technique combining restriction digestion and selective PCR amplification of genomic DNA fragments. Developed by Vos et al., 1995. AFLP detects DNA polymorphisms at the genomic level and is highly reproducible and sensitive. Used in genetic mapping, diversity studies, phylogenetics, and marker-assisted selection. Principle AFLP relies on restriction digestion of genomic DNA, followed by ligation of adaptors and PCR amplification of a subset of fragments. Polymorphism arises due to variations in restriction sites, fragment length, insertions, or deletions. Key idea: Restriction digestion → Adaptor ligation → Selective amplification → Gel separation → Detection of polymorphic bands Materials Required Genomic DNA Restriction enzymes (usually EcoRI and MseI) Adaptors complementary to restriction sites PCR reagents: Taq polymerase, dNTPs, buffer, Mg²⁺ Primers complementary to adaptors with selective nucleotides Thermal cycler Polyacrylamide or agarose ...
Post a Comment
Read more

❥ Southern Blotting Notes

Southern Blotting  ❥ 𓆞❥ 𓆞❥ 𓆞❥ 𓆞❥ 𓆞❥ 𓆞❥ 𓆞❥ 𓆞❥ 𓆞❥  Introduction Southern blotting is a molecular biology technique used for the detection of specific DNA sequences in a complex mixture of DNA. It was developed by Edwin M. Southern in 1975. The method involves restriction digestion of DNA, separation by gel electrophoresis, transfer (blotting) onto a membrane, and hybridization with a labeled DNA probe. Principle of Southern Blotting The technique is based on the principle of complementary base pairing. A single-stranded labeled DNA probe hybridizes specifically with its complementary DNA sequence immobilized on a membrane. Detection of the label confirms the presence and size of the target DNA fragment. Steps Involved in Southern Blotting. 1. Isolation of DNA Genomic DNA is extracted from cells or tissues. DNA must be pure and intact to ensure accurate results. 2. Restriction Enzyme  Digestion DNA is digested using specific restriction endonucleases. Produces DNA f...
1 comment
Read more

Secondary Databases (PROSITE, PRINTS, BLOCKS)

Secondary Databases (PROSITE, PRINTS, BLOCKS  Secondary Databases Introduction Biological databases are broadly classified into primary and secondary databases. Primary databases store raw experimental data (e.g., nucleotide or protein sequences), whereas secondary databases contain derived information obtained by analyzing primary sequence data. Secondary databases are mainly used to: Identify protein families Detect conserved motifs, patterns, and domains Predict protein function Study structure–function relationships Examples of secondary databases include PROSITE, PRINTS, BLOCKS, Pfam, etc. 1. PROSITE Database Definition PROSITE is a secondary database that documents protein domains, families, and functional sites in the form of patterns and profiles. Developed by Swiss Institute of Bioinformatics (SIB) Maintained along with UniProt Principle PROSITE is based on the idea that functionally important regions of proteins are conserved during evolution. These conserved regions can ...
Post a Comment
Read more

DNA-Mediated Gene Transfer – Detailed Notes

DNA-Mediated Gene Transfer – Detailed Notes 1. Definition DNA-mediated gene transfer refers to the direct introduction of exogenous DNA into a host cell’s genome or cytoplasm without using viral or bacterial vectors. It is a physical or chemical approach to achieve gene delivery. Also called direct gene transfer. 2 . Principle Foreign DNA is delivered into host cells through physical or chemical methods. DNA may integrate into the host genome (stable transformation) or remain episomal (transient expression). Expression depends on: DNA sequence and promoter Type of host cell Delivery efficiency 3. Types of DNA-Mediated Gene Transfer A. Physical Methods These methods use physical forces to introduce DNA into cells. Microinjection DNA is injected directly into the nucleus or cytoplasm using a glass micropipette. Used in: animal embryos, oocytes, plant protoplasts Advantages: Precise, can deliver large DNA fragments Limitations: Labor-intensive, requires specialized equipment, low throughp...
Post a Comment
Read more

Single Nucleotide Polymorphisms (SNPs) – Detailed Notes

Single Nucleotide Polymorphisms (SNPs) – Detailed Notes 1. Definition SNPs are single base-pair variations in the DNA sequence that occur at a specific position in the genome among individuals of a species. Example: At a specific locus, one individual may have A while another has G: Copy code Individual 1: …A T C G A T…   Individual 2: …A T C G G T… SNPs are the most common type of genetic variation in most organisms. 2. Characteristics of SNPs Single base change: Involves substitution of one nucleotide for another (A↔G, C↔T). Biallelic nature: Most SNPs have only two alleles in a population. Widespread in the genome: Found in coding regions (exons), non-coding regions (introns, promoters, intergenic regions). Stable inheritance: Passed from generation to generation like other genetic markers. Frequency: Occur approximately every 100–300 bp in the human genome. 3 . Types of SNPs SNPs are categorized based on location or effect on gene function: A. Based on genomic location Cod...
Post a Comment
Read more

SSR (Simple Sequence Repeat) Marker

SSR (Simple Sequence Repeat) Markers – Detailed Notes Introduction SSR markers, also called microsatellites, are short tandem repeats (1–6 bp) of DNA sequences found throughout the genome. Examples: (A)n, (CA)n, (GATA)n, where n is the number of repeat units. SSRs are highly polymorphic, co-dominant, and locus-specific, widely used in genetic mapping, variety identification, population genetics, and marker-assisted selection (MAS). SSRs are similar to STRs; in plants and animals, the term SSR is more commonly used in molecular breeding, while STR is used more in forensics and human genetics. Structure of SSR Repeat motif: 1–6 bp Number of repeats: Variable among individuals → basis of polymorphism Flanking regions: Conserved sequences used to design specific PCR primers SSR loci are generally abundant in non-coding regions, though some occur in genes. Principle SSR markers exploit variation in the number of repeat units at a specific locus. PCR amplification using primers flanking the...
Post a Comment
Read more

Protein Structure Database (PDB)

Protein Structure Database (PDB) Introduction The Protein Structure Database (PDB) is the primary global repository for the three-dimensional (3D) structures of biological macromolecules such as proteins, nucleic acids, and protein–ligand complexes. These structures are determined experimentally using techniques like X-ray crystallography, Nuclear Magnetic Resonance (NMR) spectroscopy, and Cryo-Electron Microscopy (Cryo-EM). PDB plays a vital role in understanding: Protein structure and function Molecular interactions Drug discovery and design Structural biology and bioinformatics History and Development Established in 1971 Founded by Brookhaven National Laboratory (USA) Initially contained only 7 protein structures Now maintained by the Worldwide Protein Data Bank (wwPDB) Members of wwPDB RCSB PDB (USA) PDBe (Europe) PDBj (Japan) BMRB (Biological Magnetic Resonance Data Bank) Objectives of PDB To collect, store, and distribute 3D structural data of biomolecules To provide free and ope...
Post a Comment
Read more

GEL RETARDATION ANALYSIS

GEL RETARDATION ANALYSIS (EMSA – Electrophoretic Mobility Shift Assay) Introduction Gel retardation analysis, also known as Electrophoretic Mobility Shift Assay (EMSA), is a widely used in vitro technique for studying DNA–protein and RNA–protein interactions. The method is based on the observation that a DNA–protein complex migrates more slowly than free DNA during non-denaturing gel electrophoresis, resulting in a mobility shift or “retardation”. EMSA is extensively used to study transcription factor binding, regulatory DNA elements, and binding specificity. Definition Gel retardation analysis (EMSA) is a technique used to detect and analyze binding interactions between nucleic acids and proteins by observing the reduced electrophoretic mobility of nucleic acid–protein complexes compared to free nucleic acids. Principle A labeled DNA or RNA probe is incubated with a specific binding protein. When binding occurs, a nucleic acid–protein complex is formed. This complex has a larger size ...
Post a Comment
Read more

Agrobacterium & CaMV-Mediated Gene Transfer –

Agrobacterium and CaMV-Mediated Gene Transfer – Detailed Notes 1. Introduction Gene transfer in plants is often achieved by exploiting natural genetic mechanisms of Agrobacterium tumefaciens and Cauliflower Mosaic Virus (CaMV). These systems allow stable introduction of foreign genes into plant genomes for transgenic plant development. 2. Agrobacterium-Mediated Gene Transfer 2.1 Definition Agrobacterium-mediated gene transfer uses the natural ability of Agrobacterium tumefaciens, a soil bacterium, to transfer a part of its DNA (T-DNA) into plant cells. T-DNA integrates into the plant nuclear genome, enabling stable transformation. 2.2 Mechanism Recognition and attachment Agrobacterium detects phenolic compounds secreted by wounded plant cells. These compounds activate virulence (vir) genes on the Ti (tumor-inducing) plasmid. Activation of vir genes VirA (sensor kinase) and VirG (response regulator) induce expression of other vir genes (VirB, VirC, VirD, VirE). T-DNA processing and tran...
Post a Comment
Read more

SCAR (Sequence Characterized Amplified Region) Markers

SCAR (Sequence Characterized Amplified Region) Markers   Introduction SCAR markers are PCR-based DNA markers derived from RAPD, AFLP, or other random markers. Developed by Paran and Michelmore in 1993 to convert dominant, less reproducible markers into specific, reproducible, co-dominant markers. SCAR markers are locus-specific, reproducible, and sequence-characterized, making them ideal for marker-assisted selection (MAS). Principle SCAR markers are designed based on known DNA sequences obtained from cloned RAPD/AFLP fragments. Specific primers (18–24 bp) are synthesized to amplify a single, defined locus. The PCR amplification of this region generates a distinct band, which is highly reproducible and can distinguish homozygotes from heterozygotes if designed as co-dominant. Key idea: Random marker (e.g., RAPD) → Cloning & sequencing → Design specific primers → PCR → SCAR marker Materials Required Genomic DNA from the organism Specific primers (18–24 bp) designed from sequence...
Post a Comment
Read more